tiprankstipranks
Bridgebio Pharma (BBIO)
NASDAQ:BBIO
US Market
BBIO
BridgeBio Pharma
RESEARCH TOOLSreports
Want to see BBIO full AI Analyst Report?

BridgeBio Pharma (BBIO) Stock News & Sentiment

1,480 Followers
BridgeBio Files FDA NDA for Encaleret in ADH1
Premium
Company Announcements
BridgeBio Files FDA NDA for Encaleret in ADH1
6d ago
8K
BBIO
BridgeBio Pharma Signals Atruvio‑Led Turnaround
Premium
Company Announcements
BridgeBio Pharma Signals Atruvio‑Led Turnaround
10d ago
BBIO
BridgeBio Pharma Launches New $500 Million ATM Program
Premium
Company Announcements
BridgeBio Pharma Launches New $500 Million ATM Program
11d ago
8K
BBIO
BridgeBio Pharma Announces $500 Million Stock Repurchase Program
Premium
Company Announcements
BridgeBio Pharma Announces $500 Million Stock Repurchase Program
12d ago
8K
BBIO
Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
Premium
Ratings
Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang
20d ago
BBIO
3 Best Stocks to Buy This Week, According to Analysts – April 26-May 1
Premium
Market News
3 Best Stocks to Buy This Week, According to Analysts – April 26-May 1
22d ago
ZS
BBIO
BridgeBio Buy Rating Reiterated as Analyst Sees Extended Patent Runway, Delayed Tafamidis Competition and Maintains $100 Price Target
Premium
Ratings
BridgeBio Buy Rating Reiterated as Analyst Sees Extended Patent Runway, Delayed Tafamidis Competition and Maintains $100 Price Target
22d ago
BBIO
More BBIO News >

BBIO News on the Web

Why BridgeBio Pharma Shares Are Sliding Today
TipRanks News
Bearish
Texas Instruments upgraded, Circle downgraded: Wall Street’s top analyst calls
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX)
TipRanks News
Neutral
BridgeBio initiated with an Outperform at RBC Capital
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)
TipRanks News
Bullish
Piper Sandler Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)
TipRanks News
Neutral
BridgeBio: Advancing First-in-Class LGMD Therapy and Blockbuster ATTR Franchise Underpin Reiterated Buy and $100 Target
TipRanks News
Neutral
BridgeBio Files NDA for LGMD2I/R9 Oral Therapy
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
BBIO
Sector Average
Media Buzz
This Week4 articles
Weekly Average13.25 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BBIO’s Media Buzz Sentiment?
4 articles about BBIO were published this week. In an average week, 13.25 articles are published.
    What is BBIO’s weekly average amount of articles?
    In an average week, 13.25 articles about BBIO are published.
      What is BBIO’s News Sentiment?
      99% of articles about BBIO were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        HTFLHeartFlow, Inc.
        PGENPrecigen
        Showing the stocks with the most bullish news sentiment over the past week